TRPV1 modulates the inflammatory response of endothelial cells, therefore, activation of TRPV1 should be considered as a new potential therapeutic target for the treatment of inflammatory vascular diseases, especially for atherosclerosis. This evidence concerns the gene TRPV1 and atherosclerosis.